Bain Capital Life Sciences Investors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Hold |
|
|||||
|
2025
Q1 | $2.98M | Hold |
|
|||||
|
2024
Q4 | $12.4M | Hold |
|
|||||
|
2024
Q3 | $16.4M | Hold |
|
|||||
|
2024
Q2 | $17.4M | Hold |
|
|||||
|
2024
Q1 | $38.8M | Hold |
|
|||||
|
2023
Q4 | $20.1M | Hold |
|
|||||
|
2023
Q3 | $11M | Hold |
|
|||||
|
2023
Q2 | $28.5M | Hold |
|
|||||
|
2023
Q1 | $35.6M | Hold |
|
|||||
|
2022
Q4 | $50.8M | Hold |
|
|||||
|
2022
Q3 | $58.6M | Hold |
|
|||||
|
2022
Q2 | $40M | Buy |
|
|||||
|
2022
Q1 | $26M | Buy |
|
|||||
|
2021
Q4 | $33.5M | Buy |
|
|||||
|
2021
Q3 | $34.9M | Hold |
|
|||||
|
2021
Q2 | $50.2M | Hold |
|
|||||
|
2021
Q1 | $59.8M | Buy |
|
|||||
|
2020
Q4 | $91.7M | Hold |
|
|||||
|
2020
Q3 | $64.2M | Hold |
|
|||||
|
2020
Q2 | $80.6M | Buy |
|